UPDATED Sep 26, 2025
Discover Belgian Pharmaceuticals & Biotech Growth Stocks that are on the BEL20. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
HYL | €5.84 | -3.0% | 2.8% | €163.5m | €13.00 | PS18.4x | E78.9% | n/a | ||
ARGX | €613.20 | -1.9% | 28.1% | €37.5b | €724.38 | PE34.3x | E26.4% | n/a | ||
UCB | €196.90 | -3.1% | 22.0% | €37.4b | €229.06 | PE28.1x | E17.5% | 0.7% | ||
TUB | €159.00 | -4.8% | 21.2% | €7.1b | €186.50 | PE76.3x | n/a | 0.7% | ||
OXUR | €0.019 | -15.3% | -95.5% | €947.1k | n/a | PE8x | n/a | n/a | ||
BIOS | €0.0025 | 0% | -67.1% | €1.6m | n/a | PE-0.2x | n/a | n/a | ||
CYAD | €0.31 | 3.0% | 15.1% | €13.8m | n/a | PS74.4x | n/a | n/a | ||
ALEMS | €5.50 | -4.2% | -18.6% | €23.3m | n/a | PE42.6x | n/a | n/a |